Q14145 (KEAP1_HUMAN) Homo sapiens (Human)

Kelch-like ECH-associated protein 1 UniProtKBInterProSTRINGInteractive Modelling

624 aa; Sequence (Fasta) ; 4 identical sequences: Pan troglodytes: A0A6D2X5C6, H2QFB9; Pan paniscus: A0A2R9BRR8; Gorilla gorilla gorilla: G3QHR9

Available Structures

99 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFA Heteromer
Q16236;
327-612
Assess
Crystal Structure of the Kelch-Neh2 Complex Heteromer
Q16236;
325-609
Assess
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexes Heteromer
Q16236;
325-609
Assess
De novo design and crystallographic validation of antibodies targeting a pre-selected epitope Heteromer
325-609
Assess
crystal structure of the KEAP1-NEH2 complex Heteromer
Q16236;
325-609
ACT;
Assess
KEAP1 IN COMPLEX WITH PEPTIDE 8 Heteromer
Q16236;
325-609
ACT;
Assess
Kelch domain of human Keap1 bound to Nrf2 ETGE peptide Heteromer
Q16236;
326-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEFL Heteromer
Q16236;
326-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEFA Heteromer
Q16236;
327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-DEETGE] Heteromer
Q16236;
327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDPETGE-NH2 Heteromer
Q16236;
327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 peptide, ADEETGEAA Heteromer
Q16236;
327-609
SO4;
Assess
Kelch domain of human KEAP1 bound to Nrf2 peptide, LDEETGEAL Heteromer
Q16236;
327-609
SO4;
Assess
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-(BAla)DPETGE-NH2 Heteromer
Q16236;
327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GDEETGE] Heteromer
Q16236;
328-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 linear peptide, Ac-GDEETGE-NH2 Heteromer
Q16236;
330-609
Assess
Crystal structure of human CUL3 N-terminal domain bound to KEAP1 BTB and 3-box Heteromer
Q13618;
51-204
Assess
The structure of the F64A, S172A mutant Keap1-BTB domain in complex with SKP1-FBXL17 Heteromer
P63208; Q9UF56;
50-179
Assess
Structure of a substrate-bound DQC ubiquitin ligase Heteromer
P63208; Q13616; Q9UF56;
50-179
Assess
STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S,2R)-2-[(1S)-1-[(1-oxo-2,3-dihydro-1H-isoindol-2-Yl)methyl]-…homo-3-mer325-611
2FS;ACT;
Assess
Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-…homo-3-mer325-609
1VX; 10×ACT;
Assess
Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-…homo-3-mer326-609
1VW;ACT;
Assess
Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)me…homo-2-mer321-609
ACT;1VV;NA;
Assess
Crystal Structure of the KELCH domain of human KEAP1homo-2-mer324-609
FMT;NA;
Assess
ProteinMYhomo-2-mer324-609
Assess
crystal structure of a KEAP1 mutanthomo-2-mer325-609
10×ACT;NA;
Assess
Keap1 - peptide complexhomo-2-mer325-609
EDO;ACT;NA;
Assess
Keap1 - peptide complexhomo-2-mer325-609
10×ACT;EDO;CL;NA;
Assess
BTB domain of KEAP1 in complex with CDDOhomo-2-mer49-180
SXJ;
Assess
Crystal Structure of Human KEAP1 BTB Domain in Complex with isoxazoline-based inhibitorhomo-2-mer50-180
D8N;
Assess
The Crystal Structure of KEAP1 from Biortus.homo-2-mer49-179
Assess
BTB domain of KEAP1 C151W mutanthomo-2-mer49-179
Assess
Crystal structure of the BTB domain human Keap1homo-2-mer50-179
Assess
Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64014homo-2-mer50-179
TX6;
Assess
Crystal structure of Keap1 BTB domain in complex with dimethyl fumarate (DMF)homo-2-mer50-179
9HB;
Assess
The structure of S172A Keap1-BTB domainhomo-2-mer51-179
Assess
The structure of F64, S172A Keap1-BTB domainhomo-2-mer51-179
Assess
The structure of V98A S172A Keap1-BTB domainhomo-2-mer51-179
Assess
BTB domain of KEAP1 in complex with MEFhomo-2-mer50-178
9J3;
Assess
Crystal Structure of Human KEAP1 BTB Domain in Complex with Small Molecule TX64063homo-2-mer50-177
58E;
Assess
Crystal structure of Keap1 in complex with dimethyl fumarate (DMF)monomer319-613
EOU;ACT;PG5;SO4;
Assess
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
T6I;SO4;
Assess
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
SIU;SO4;
Assess
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1/Nrf2 PPI Inhibitor for Treatment of …monomer321-613
SGO;DTT;SO4;
Assess
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 5 (ortho-WRCDPE…monomer324-615
SO4;CL;EDO;GOL;NA;
Assess
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 4 (ortho-WRCDEE…monomer324-615
SO4;CL;EDO;GOL;NA;
Assess
Kelch domain of KEAP1 in complex with a ortho-dimethylbenzene linked cyclic peptide 11 (ortho-WRCNP…monomer324-614
CL;EDO;GOL;NA;
Assess
Kelch domain of KEAP1 in complex with ortho-dimethylbenzene linked cyclic peptide 3 (ortho-WRCDEETG…monomer325-614
SO4;CL;GOL;EDO;
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[BAL-NPETGE]monomer326-614
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GEPETGE]monomer326-614
Assess
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[LhA-DEETGE]monomer326-614
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPETGE]monomer326-614
Assess
Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-oxo-4H-1-benzopyran-2-car…monomer325-613
SO4;
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[DhA-GDPET(bAla)E]monomer326-614
Assess
1.35 angstrom structure of the Kelch domain of Keap1monomer322-609
Assess
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexesmonomer322-609
Assess
Crystal structure of the Kelch domain of human Keap1monomer322-609
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPETGE]monomer327-614
Assess
Crystal Structure of Keap1 Soaked with Synthetic Small Molecularmonomer322-609
FUU;
Assess
Crystal Structure of Keap1 in Complex with Synthetic Small Molecular based on a co-crystallizationmonomer322-609
FUU;
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDEEAGE]monomer327-614
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[Ahx-DPETGE]monomer327-614
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GDPEAGE]monomer327-614
Assess
Crystal structure of cpd 15 bound to Keap1 Kelch domainmonomer322-609
PO4;4ID;
Assess
Crystal structure of the Kelch domain in complex with 11 amino acid peptide (model of the ETGE loop)monomer322-609
NA;
Assess
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6kmonomer323-609
GED;
Assess
Crystal structure of N-(4-((4-methoxy-N-(2,2,2-trifluoroethyl)phenyl)sulfonamido)isoquinolin-1-yl)-…monomer324-609
Q5V;FMT;DMS;NA;
Assess
Keap1 Kelch domain (residues 322-609) in complex with 6imonomer324-609
GCI;
Assess
Crystal structure of 2,2'-(naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetamid…monomer324-609
41P;
Assess
KEAP1 Kelch domain in complex with Compound 9monomer325-609
GOL;DMS;08A;
Assess
Crystal structure of N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthale…monomer325-609
11×FMT;Q5Y;NA;
Assess
Keap1 - inhibitor complexmonomer325-609
EDO;GX8;NA;
Assess
Crystal structure of cpd 16 bound to Keap1 Kelch domainmonomer325-609
IQK;
Assess
Keap1 compound complexmonomer325-609
91M;CL;
Assess
Keap1 compound complexmonomer325-609
9IB;CL;
Assess
Crystal structure of the Keap1 Kelch domain in complex with a tetrapeptidemonomer325-609
Assess
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with NXPZ-2monomer325-609
GFD;
Assess
Keap1 compound complexmonomer325-609
92I;CL;
Assess
Keap1 macrocycle complexmonomer325-609
Q9E;NA;CL;
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAEETGE]monomer325-609
Assess
Crystal Structures of apo Keap1, Keap1-peptide, and Keap1-compound complexesmonomer325-609
12O;
Assess
Keap1 compound complexmonomer325-609
9P0;CL;
Assess
Kelch domain of human KEAP1 bound to Nrf2 cyclic peptide, c[GAPETGE]monomer325-609
Assess
Keap1 compound complexmonomer325-609
8ZL;NA;CL;
Assess
KEAP1 IN COMPLEX WITH COMPOUND 6monomer325-609
LQ8;ACT;
Assess
Crystal structure of Keap1_6kmonomer325-609
HB6;
Assess
Crystal structure of Keap1 Kelch domain (residues 322-609) in complex with 6emonomer325-609
GDJ;
Assess
KEAP1 IN COMPLEX WITH COMPOUND 44monomer326-609
ACT;
Assess
Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-amino-1,7-dihydro-6H-pyra…monomer326-609
SO4;1XM;
Assess
KEAP1 Kelch domain in complex with Compound 2monomer326-609
FMT;PKG;
Assess
KEAP1 IN COMPLEX WITH COMPOUND 23monomer326-609
LQK;
Assess
Kelch domain of human Keap1 in open unliganded conformationmonomer327-609
SO4;
Assess
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[AVA-DPETGE]monomer327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[GABA-DPETGE]monomer327-609
Assess
Kelch domain of human KEAP1 bound to Nrf2-based cyclic peptide, c[BAL-DEETGE]monomer327-609
SO4;
Assess
Kelch domain of human Keap1 bound to mutant Nrf2 EAGE peptidemonomer330-609
SO4;
Assess
Kelch domain of human Keap1 bound to inhibitory small molecule fragment: hydroxyphenyl propionic ac…monomer330-609
HPP;
Assess
BTB domain of KEAP1 in complex with XX3monomer51-180
XXT;
Assess
BTB domain of KEAP1monomer50-179
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2dyh.1.Amonomer0.91324-619
96.21
Assess
6wcq.1.Cmonomer0.7550-179
99.84
Assess